VitroScreen m-Dermis (scaffold free organoid) is produced by human primary dermal fibroblasts and with donors of different age : it has shown interesting features during 21 days in culture conditions.
By precisely mimicking ECM production in vivo, the micro-dermis model resulted to be an unique and innovative tool for active ingredients screening on dermal matrix deposition and remodeling by VitroScreen Multiple Endpoints Approach that includes also 3D imaging techniques.
Marisa Méloni
marisa.meloni@vitroscreen.com
Via Mosé Bianchi,103
20149 Milano
Special Webinar: Thursday, 27 March 2025 at 3 p.m. Cosmetic active ingredients and products are…
Editor Tim Probert caught up with four participants - Anne Charpentier, CEO of Skinobs; Mike…
Mieke Meintjes 27 February 2025 Scientists at Florida International University and the University of Miami,…
